IBC’s 5th Annual Biosimilars Asia 2014
With the theme of "Collaborative Development and Successful Commercialization", IBC’s 5th Annual Biosimilars Asia 2014 will take place at Grand Hyatt Shanghai during May 20-23, 2014. It will will have focus discussions on partnerships and emerging models of collaboration that provide win-win for regional companies and MNCs.
IBC’s 5th Annual Biosimilars Asia 2014 will bring together senior level biosimilars development, manufacturing and commercialization decision makers from Asia and globally. It provides an unrivalled platform to find solutions to the most pressing strategic challenges as well as innovations in development of biosimilars.
IBC’s 5th Annual Biosimilars Asia 2014 is co-located with Cell Line Development and Engineering Asia and Biomanufacturing 2014 as part of the Biopharma Development & Production (BDP) Week.
Concurrently Conferences
IBC's 4th Annual Biomanufacturing Asia
IBC's 3rd Annual Cell Line Development & Engineering Asia 2014
-
Regulatory Updates from Key markets: China, India, Korea, Taiwan and Malaysia
-
Advances in Biosimilars R&D
-
Challenges in Clinical Development
-
Leveraging on the Growing Biomanufacturing Capabilities in Asia to Minimize Cost and Optimize Quality
-
Examining Risk and Opportunities of the Evolving China Biosimilars Market
-
Legal and IP Issues
-
Strategies for Commercialization and Market Access